Pharmacy Services Agreement Nz

The new funding model will focus on patients and allow pharmacists to better ensure that drugs are respected and respected, especially for patients with multiple comorbidity and for the use of many medications. Pharmacists are also encouraged to work with doctors and nurses and be part of the health team. The Guild appreciates the reasons that led to the introduction of a moratorium on the granting of standard DHB agreements for basic pharmacies for new pharmacies in the Community for a period of three to six months, without notice for the sector. Under the previous model, pharmacies were paid for the amount of drugs dispensed. The resulting growth in pharmacy spending has become unsustainable and the link between funding and volume costs has been unsustainable with patient outcomes. In 2009/2010, the total cost of the tax was $320 million, of which $82 million was spent on the Close Control Pharmaceutical Schedule Rule (now known as dispensing Frequency). Of the $82 million spent on Close Control, more than half ($46 million) was spent on the weekly tax. THE PHARMAC announces changes to the rules for the distribution of frequencies, in accordance with the new pharmacy services, to support compliance and respect for medicines for patients. Pharmacists, DHBs, pharmacists, PHARMAzie, PHARMAC and the entire health sector have developed the new service model over the past two years. A steering group consisting of a representative of the RNZCGP met every six weeks until November 2011. Meetings were held with the GP Leaders Forum, the Community Pharmacy Leaders Group, RNZCGP, NZMA, GPNZ and the Pharmaceutical Society to gather feedback on the proposed changes. All organizations are very supportive of this approach. Key Findings: The main themes that emerged were: pharmacists supported the philosophy behind the CPSA, pharmacists` understanding of the CPSA, the implementation of CPSA-related services, the perceived impact on patient outcomes and the future viability of the CPSA.

Overall, pharmacists supported the referral of funding to patient-centred services, but pharmacy owners reported difficulties in understanding the funding model, leading to income uncertainties.